Suppr超能文献

采用质量源于设计方法,利用多元方法研究片剂在加速稳定性条件下的溶出度变化。

A Quality by Design approach to investigate tablet dissolution shift upon accelerated stability by multivariate methods.

机构信息

Pfizer Inc., Peapack, NJ 07977, USA.

出版信息

Eur J Pharm Biopharm. 2011 May;78(1):141-50. doi: 10.1016/j.ejpb.2010.12.012. Epub 2010 Dec 17.

Abstract

This paper presents the use of experimental design, optimization and multivariate techniques to investigate root-cause of tablet dissolution shift (slow-down) upon stability and develop control strategies for a drug product during formulation and process development. The effectiveness and usefulness of these methodologies were demonstrated through two application examples. In both applications, dissolution slow-down was observed during a 4-week accelerated stability test under 51°C/75%RH storage condition. In Application I, an experimental design was carried out to evaluate the interactions and effects of the design factors on critical quality attribute (CQA) of dissolution upon stability. The design space was studied by design of experiment (DOE) and multivariate analysis to ensure desired dissolution profile and minimal dissolution shift upon stability. Multivariate techniques, such as multi-way principal component analysis (MPCA) of the entire dissolution profiles upon stability, were performed to reveal batch relationships and to evaluate the impact of design factors on dissolution. In Application II, an experiment was conducted to study the impact of varying tablet breaking force on dissolution upon stability utilizing MPCA. It was demonstrated that the use of multivariate methods, defined as Quality by Design (QbD) principles and tools in ICH-Q8 guidance, provides an effective means to achieve a greater understanding of tablet dissolution upon stability.

摘要

本文采用实验设计、优化和多元统计技术研究了片剂在稳定性研究中溶出度缓慢变化(滞后)的根本原因,并为药物制剂的开发过程制定了控制策略。通过两个应用实例证明了这些方法的有效性和实用性。在两个应用中,在 51°C/75%RH 存储条件下进行的 4 周加速稳定性试验中,观察到溶出度缓慢下降。在应用案例 I 中,进行了实验设计以评估设计因素对稳定性下关键质量属性(CQA)的溶出度的相互作用和影响。通过实验设计(DOE)和多元分析研究了设计空间,以确保在稳定性下具有期望的溶出度曲线和最小的溶出度滞后。进行了多元技术,例如稳定性下整个溶出度曲线的多向主成分分析(MPCA),以揭示批次间的关系,并评估设计因素对溶出度的影响。在应用案例 II 中,利用 MPCA 研究了片剂破碎力变化对稳定性下溶出度的影响。结果表明,使用多元方法(ICH-Q8 指南中定义的 QbD 原则和工具)是深入了解稳定性下片剂溶出度的有效手段。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验